<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38104129</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2158-3188</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>Translational psychiatry</Title><ISOAbbreviation>Transl Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-&#x3b2;-associated pathology in APP/PS1 mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>396</StartPage><MedlinePgn>396</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">396</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41398-023-02692-z</ELocationID><Abstract><AbstractText>Although there are indications of a trend towards less severe acute respiratory symptoms and a decline in overall lethality from the novel Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), more and more attention has been paid to the long COVID, including the increased risk of Alzheimer's disease (AD) in COVID-19 patients. In this study, we aim to investigate the involvement of N-terminal amyloid precursor protein (APP) in SARS-CoV-2-induced amyloid-&#x3b2; (A&#x3b2;) pathology. Utilizing both in vitro and in vivo methodologies, we first investigated the interaction between the spike protein of SARS-CoV-2 and N-terminal APP via LSPR and CoIP assays. The in vitro impacts of APP overexpression on virus infection were further evaluated in HEK293T/ACE2 cells, SH-SY5Y cells, and Vero cells. We also analyzed the pseudovirus infection in vivo in a mouse model overexpressing human wild-type APP. Finally, we evaluated the impact of APP on pseudovirus infection within human brain organoids and assessed the chronic effects of pseudovirus infection on A&#x3b2; levels. We reported here for the first time that APP, the precursor of the A&#x3b2; of AD, interacts with the Spike protein of SARS-CoV-2. Moreover, both in vivo and in vitro data further indicated that APP promotes the cellular entry of the virus, and exacerbates A&#x3b2;-associated pathology in the APP/PS1 mouse model of AD, which can be ameliorated by N-terminal APP blockage. Our findings provide experimental evidence to interpret APP-related mechanisms underlying AD-like neuropathology in COVID-19 patients and may pave the way to help inform risk management and therapeutic strategies against diseases accordingly.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Zhejiang University School of Medicine, 310058, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, 310015, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, 550025, Guiyang, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Junsheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, 550025, Guiyang, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lei</LastName><ForeName>Zhifeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, 550025, Guiyang, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fengning</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, 550025, Guiyang, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Ling-Hui</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, 310015, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ximei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Zhejiang University School of Medicine, 310058, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Song</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2713-9136</Identifier><AffiliationInfo><Affiliation>First Affiliated Hospital of Dalian Medical University, 116021, Dalian, Liaoning, China. lisong@dmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1703-8596</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, 310015, Hangzhou, Zhejiang, China. tanjun@anyuhz.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, 550025, Guiyang, Guizhou, China. tanjun@anyuhz.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Psychiatry</MedlineTA><NlmUniqueID>101562664</NlmUniqueID><ISSNLinking>2158-3188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>16</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38104129</ArticleId><ArticleId IdType="pmc">PMC10725492</ArticleId><ArticleId IdType="doi">10.1038/s41398-023-02692-z</ArticleId><ArticleId IdType="pii">10.1038/s41398-023-02692-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M. Liquid&#x2013;liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017;8:275. doi: 10.1038/s41467-017-00480-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00480-0</ArticleId><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelkmans L, Helenius A. Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol. 2003;15:414&#x2013;22. doi: 10.1016/s0955-0674(03)00081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0955-0674(03)00081-4</ArticleId><ArticleId IdType="pubmed">12892781</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008;18:290&#x2013;301. doi: 10.1038/cr.2008.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2008.15</ArticleId><ArticleId IdType="pmc">PMC7091891</ArticleId><ArticleId IdType="pubmed">18227861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamorano Cuervo N, Grandvaux N. ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 2020;9 10.7554/eLife.61390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652413</ArticleId><ArticleId IdType="pubmed">33164751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, et al. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther. 2021;6:233. doi: 10.1038/s41392-021-00653-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00653-w</ArticleId><ArticleId IdType="pmc">PMC8193598</ArticleId><ArticleId IdType="pubmed">34117216</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706&#x2013;14. doi: 10.1038/s41586-022-04474-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281&#x2013;92e286. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, Wan L, Yan Q, Wang X, Zhang J, Yang X, et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020;2:1391&#x2013;1400. doi: 10.1038/s42255-020-00324-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00324-0</ArticleId><ArticleId IdType="pubmed">33244168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Qiu Z, Hou Y, Deng X, Xu W, Zheng T, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;31:126&#x2013;40. doi: 10.1038/s41422-020-00460-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00460-y</ArticleId><ArticleId IdType="pmc">PMC7791157</ArticleId><ArticleId IdType="pubmed">33420426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;60. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Shao L, Lin Z, Long QX, Yuan H, Cai L, et al. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct Target Ther. 2022;7:261. doi: 10.1038/s41392-022-01118-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01118-4</ArticleId><ArticleId IdType="pmc">PMC9340718</ArticleId><ArticleId IdType="pubmed">35915083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jocher G, Grass V, Tschirner SK, Riepler L, Breimann S, Kaya T, et al. ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion. EMBO Rep. 2022;23:e54305. doi: 10.15252/embr.202154305.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202154305</ArticleId><ArticleId IdType="pmc">PMC9171409</ArticleId><ArticleId IdType="pubmed">35527514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, et al. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res. 2022;32:24&#x2013;37. doi: 10.1038/s41422-021-00595-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00595-6</ArticleId><ArticleId IdType="pmc">PMC8617373</ArticleId><ArticleId IdType="pubmed">34837059</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S, Zhang J, Fang Y, Lu S, Wu J, Zheng X, et al. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism. J Hematol Oncol. 2021;14:72. doi: 10.1186/s13045-021-01082-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01082-6</ArticleId><ArticleId IdType="pmc">PMC8082485</ArticleId><ArticleId IdType="pubmed">33926500</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen XR, Geng R, Li Q, Chen Y, Li SF, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83. doi: 10.1038/s41392-022-00919-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00919-x</ArticleId><ArticleId IdType="pmc">PMC8914143</ArticleId><ArticleId IdType="pubmed">35277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021;218 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle MF. Central nervous system outcomes of COVID-19. Transl Res. 2022;241:41&#x2013;51. doi: 10.1016/j.trsl.2021.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8482653</ArticleId><ArticleId IdType="pubmed">34601116</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;9. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;63. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18:955&#x2013;65. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Kodavati M, Provasek VE, Rao KS, Mitra S, Hamilton DJ, et al. SARS-CoV-2 and the central nervous system: emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res Rev. 2022;80:101687. doi: 10.1016/j.arr.2022.101687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101687</ArticleId><ArticleId IdType="pmc">PMC9288264</ArticleId><ArticleId IdType="pubmed">35843590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen WB, Elahi M, Logue J, Yang P, Baracco L, Reece EA, et al. SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer&#x2019;s-like neuropathology. 2022. bioRxiv 10.1101/2022.01.31.478476.</Citation></Reference><Reference><Citation>Green R, Mayilsamy K, McGill AR, Martinez TE, Chandran B, Blair LJ, et al. SARS-CoV-2 infection increases the gene expression profile for Alzheimer&#x2019;s disease risk. Mol Ther Methods Clin Dev. 2022;27:217&#x2013;29. doi: 10.1016/j.omtm.2022.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.09.007</ArticleId><ArticleId IdType="pmc">PMC9508696</ArticleId><ArticleId IdType="pubmed">36187720</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs E, Trageser K, Naughton S, Yang EJ, Mathew B, Van Hyfte G, et al. Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer&#x2019;s disease individuals. 2022. bioRxiv 10.1101/2022.11.23.517706.</Citation></Reference><Reference><Citation>Camacho RC, Alabed S, Zhou H, Chang SL. Network meta-analysis on the changes of amyloid precursor protein expression following SARS-CoV-2 infection. J Neuroimmune Pharmacol. 2021;16:756&#x2013;69. doi: 10.1007/s11481-021-10012-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10012-9</ArticleId><ArticleId IdType="pmc">PMC8579188</ArticleId><ArticleId IdType="pubmed">34757528</ArticleId></ArticleIdList></Reference><Reference><Citation>Caradonna A, Patel T, Toleska M, Alabed S, Chang SL. Meta-analysis of APP expression modulated by SARS-CoV-2 infection via the ACE2 receptor. Int J Mol Sci 2022;23 10.3390/ijms23031182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8835589</ArticleId><ArticleId IdType="pubmed">35163117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Zhang DF, Zou QC, Xie X, Xu L, Feng XL, et al. SARS-CoV-2 Spike protein S2 subunit modulates gamma-secretase and enhances amyloid-beta production in COVID-19 neuropathy. Cell Discov. 2022;8:99. doi: 10.1038/s41421-022-00458-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00458-3</ArticleId><ArticleId IdType="pmc">PMC9524330</ArticleId><ArticleId IdType="pubmed">36180433</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer&#x2019;s dementia. Alzheimers Dement. 2022;18:899&#x2013;910. doi: 10.1002/alz.12556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12556</ArticleId><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A, Muller L, Ostermann PN, Gabriel E, Abida-Islam P, Muller-Schiffmann A, et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Fan A, Li S, Xiao Y, Fu Y, Chen JS, et al. APP mediates tau uptake and its overexpression leads to the exacerbated tau pathology. Cell Mol Life Sci. 2023;80:123. doi: 10.1007/s00018-023-04774-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-023-04774-z</ArticleId><ArticleId IdType="pmc">PMC11071805</ArticleId><ArticleId IdType="pubmed">37071198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Chen JS, Li S, Zhang F, Deng J, Zeng LH, et al. Amyloid precursor protein: a regulatory hub in Alzheimer&#x2019;s disease. Aging Dis. 2023. 10.14336/AD.2023.0308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10796103</ArticleId><ArticleId IdType="pubmed">37307834</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M, Miyata H, Kametani F, Nonaka T, Akiyama H, Hisanaga S, et al. Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol. 2015;129:895&#x2013;907. doi: 10.1007/s00401-015-1415-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1415-2</ArticleId><ArticleId IdType="pmc">PMC4436700</ArticleId><ArticleId IdType="pubmed">25869641</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer&#x2019;s disease. Annu Rev Neurosci 2011;34:185&#x2013;204 10.1146/annurev-neuro-061010-113613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3174086</ArticleId><ArticleId IdType="pubmed">21456963</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang T, Nicolas M, Boussicault L, Rice H, Soldano A, et al. The amyloid precursor protein is a conserved Wnt receptor. Elife 2021;10 10.7554/eLife.69199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437438</ArticleId><ArticleId IdType="pubmed">34515635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawmiller D, Habib A, Hou H, Mori T, Fan A, Tian J, et al. A novel apolipoprotein E antagonist functionally blocks apolipoprotein E interaction with N-terminal amyloid precursor protein, reduces beta-amyloid-associated pathology, and improves cognition. Biol Psychiatry. 2019;86:208&#x2013;20. doi: 10.1016/j.biopsych.2019.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2019.04.026</ArticleId><ArticleId IdType="pmc">PMC6642011</ArticleId><ArticleId IdType="pubmed">31208706</ArticleId></ArticleIdList></Reference><Reference><Citation>Satpute-Krishnan P, DeGiorgis JA, Bearer EL. Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer&#x2019;s disease. Aging Cell. 2003;2:305&#x2013;18. doi: 10.1046/j.1474-9728.2003.00069.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1474-9728.2003.00069.x</ArticleId><ArticleId IdType="pmc">PMC3622731</ArticleId><ArticleId IdType="pubmed">14677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183:1043&#x2013;57 e1015. doi: 10.1016/j.cell.2020.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Piacentini R, De Chiara G, Li Puma DD, Ripoli C, Marcocci ME, Garaci E, et al. HSV-1 and Alzheimer&#x2019;s disease: more than a hypothesis. Front Pharmacol. 2014;5:97. doi: 10.3389/fphar.2014.00097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2014.00097</ArticleId><ArticleId IdType="pmc">PMC4019841</ArticleId><ArticleId IdType="pubmed">24847267</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Q, Jovasevic V, Malikov V, Sabo Y, Morham S, Walsh D, et al. HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun. 2017;8:1522. doi: 10.1038/s41467-017-01795-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01795-8</ArticleId><ArticleId IdType="pmc">PMC5688069</ArticleId><ArticleId IdType="pubmed">29142315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Zhang XE. Construction and applications of SARS-CoV-2 pseudoviruses: a mini review. Int J Biol Sci. 2021;17:1574&#x2013;80. doi: 10.7150/ijbs.59184.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59184</ArticleId><ArticleId IdType="pmc">PMC8071765</ArticleId><ArticleId IdType="pubmed">33907521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnasinghe R, Jangra S, Ye C, Cupic A, Singh G, Martinez-Romero C, et al. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera. Nat Commun. 2022;13:3921. doi: 10.1038/s41467-022-30763-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30763-0</ArticleId><ArticleId IdType="pmc">PMC9261898</ArticleId><ArticleId IdType="pubmed">35798721</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanidi G, Lamb K, Zolotukhin S. An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc Natl Acad Sci USA. 2009;106:5059&#x2013;64. doi: 10.1073/pnas.0810614106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810614106</ArticleId><ArticleId IdType="pmc">PMC2654393</ArticleId><ArticleId IdType="pubmed">19279219</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21:255&#x2013;72. doi: 10.1038/s41576-019-0205-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0205-4</ArticleId><ArticleId IdType="pubmed">32042148</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukouli F, Rooy M, Maskos U. Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex. Aging (Albany, NY) 2016;8:3430&#x2013;49. doi: 10.18632/aging.101136.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101136</ArticleId><ArticleId IdType="pmc">PMC5270678</ArticleId><ArticleId IdType="pubmed">27999185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Li S, Lei Z, Tang Q, Mo L, Zhao X, et al. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: an alternative approach to COVID19 prevention and therapy. Int J Biol Sci. 2021;17:2957&#x2013;69. doi: 10.7150/ijbs.61476.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.61476</ArticleId><ArticleId IdType="pmc">PMC8326117</ArticleId><ArticleId IdType="pubmed">34345219</ArticleId></ArticleIdList></Reference><Reference><Citation>Strizzi S, Bernardo L, D&#x2019;Ursi P, Urbinati C, Bianco A, Limanaqi F, et al. An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein. Pharmacol Res. 2023;194:106862. doi: 10.1016/j.phrs.2023.106862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106862</ArticleId><ArticleId IdType="pubmed">37479104</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Primio C, Quaranta P, Mignanelli M, Siano G, Bimbati M, Scarlatti A, et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus. 2023;2:pgad282. doi: 10.1093/pnasnexus/pgad282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad282</ArticleId><ArticleId IdType="pmc">PMC10508204</ArticleId><ArticleId IdType="pubmed">37731949</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Cosio DS, Ali S, Kenyon NS, Jayakumar AR. Long-term sequelae of COVID-19 in experimental mice. Mol Neurobiol. 2022;59:5970&#x2013;86. doi: 10.1007/s12035-022-02932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02932-1</ArticleId><ArticleId IdType="pmc">PMC9281331</ArticleId><ArticleId IdType="pubmed">35831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12:69. doi: 10.1186/s13195-020-00640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennol MP, Ashton NJ, Moreno-Perez O, Garcia-Ayllon MS, Ramos-Rincon JM, Andres M, et al. Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes. Int J Mol Sci 2023;24 10.3390/ijms24032715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917569</ArticleId><ArticleId IdType="pubmed">36769057</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt J, Lester E, Parker R. Could SARS-CoV-2 cause tauopathy? Lancet Neurol. 2021;20:506. doi: 10.1016/S1474-4422(21)00168-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00168-X</ArticleId><ArticleId IdType="pmc">PMC8292136</ArticleId><ArticleId IdType="pubmed">34146504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP, et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood&#x2013;CSF barrier in human brain organoids. Cell Stem Cell. 2020;27:951&#x2013;61 e955. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;20. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci. 2021;24:368&#x2013;78. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann B, Schmidbauer ML, Dimitriadis K, Otto S, Knier B, Niesen WD, et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J Neurol Sci. 2020;418:117090. doi: 10.1016/j.jns.2020.117090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117090</ArticleId><ArticleId IdType="pmc">PMC7417278</ArticleId><ArticleId IdType="pubmed">32805440</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;75. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Yoo SJ, Clijsters M, Backaert W, Vanstapel A, Speleman K, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932&#x2013;49 e5915. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne BA, Hateley CL, Ong EL, Premchand N, Schmid ML, Schwab U, et al. HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms? HIV Med. 2013;14:247&#x2013;51. doi: 10.1111/j.1468-1293.2012.01050.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1293.2012.01050.x</ArticleId><ArticleId IdType="pubmed">22998022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AM, Christopher G, Jenkinson E. The psychological impact of dependency in adults with chronic fatigue syndrome/myalgic encephalomyelitis: a qualitative exploration. J Health Psychol. 2019;24:264&#x2013;75. doi: 10.1177/1359105316643376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105316643376</ArticleId><ArticleId IdType="pubmed">27098385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>